Division of Nutritional Sciences, Cornell University, Ithaca, NY, USA.
J Nutr. 2012 Apr;142(4):774-80. doi: 10.3945/jn.111.155275. Epub 2012 Feb 29.
The integration of nutrition support for infants of HIV-infected mothers is a recognized need; however, the evidence for effective programmatic solutions is weak. The objective of our study was to implement and evaluate a new infant feeding support intervention for HIV-exposed, uninfected, non-breast-fed infants 6-12 mo of age attending the Groupe Haïtien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) pediatric clinic in Port-au-Prince, Haiti. The 24-wk intervention included a lipid-based nutrient supplement, education, promotion of existing clinical services, and social support. We compared growth outcomes among intervention participants (n = 73) at start (wk 0) and end (wk 24) of intervention to a historical control group of HIV-exposed infants seen at the GHESKIO in the year prior to the intervention who would have met the intervention entrance criteria (n = 294). The intervention and historical control groups did not differ significantly at age 6 mo (wk 0). At age 12 mo (wk 24), the intervention group had a lower prevalence of underweight and stunting than the historical control group (weight-for-age Z-score < -2 SD: 6.8 vs. 20.8%, P = 0.007; length-for-age Z-score < -2 SD: 9.6 vs. 21.2%, P = 0.029). Wasting tended to be lower in the intervention group than the historical control (weight-for-length Z-score < -2 SD: 2.9 vs. 8.9%, P = 0.11). Implementation of the intervention was associated with reduced risk of growth faltering in HIV-exposed uninfected children from 6 to 12 mo of age. This is a promising intervention model that can be adapted and scaled-up to other HIV care contexts.
为感染 HIV 的母亲提供婴儿营养支持的整合是一项公认的需求;然而,有效的方案解决办法的证据仍然不足。我们的研究目的是在太子港海地肉瘤和机会性感染研究组(GHESKIO)儿科诊所为 6-12 个月大的、感染 HIV 但未感染、未进行母乳喂养的婴儿实施和评估一种新的婴儿喂养支持干预措施。该 24 周的干预措施包括使用一种基于脂质的营养补充剂、教育、促进现有临床服务和社会支持。我们比较了干预组(n = 73)在干预开始(第 0 周)和结束(第 24 周)时的生长结果与干预前一年在 GHESKIO 就诊的、符合干预进入标准的 HIV 暴露婴儿的历史对照组(n = 294)。干预组和历史对照组在 6 月龄(第 0 周)时年龄差异无统计学意义。在 12 月龄(第 24 周)时,干预组的体重不足和发育迟缓发生率低于历史对照组(体重年龄 Z 评分< -2 SD:6.8%比 20.8%,P = 0.007;身长年龄 Z 评分< -2 SD:9.6%比 21.2%,P = 0.029)。干预组的消瘦发生率低于历史对照组(体重长度 Z 评分< -2 SD:2.9%比 8.9%,P = 0.11)。该干预措施的实施与降低 6-12 月龄 HIV 未感染婴儿生长迟缓的风险相关。这是一种很有前景的干预模式,可以适应和扩展到其他 HIV 护理环境。